Sep 20, 2009 | NEWS
Findings further increase power of DNA-based testing to identify men at substantially increased risk, and will be integrated into the deCODE ProstateCancer™ test Reykjavik, ICELAND, September 20, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that a team of its...
Jul 13, 2009 | NEWS
Will be integrated into deCODE AF™ DNA-based risk assessment test, and into the deCODEme™ and deCODEme Cardio™ scans Reykjavik, ICELAND, July 13, 2009 – Scientists at deCODE genetics (Nasdaq:DCGN) and colleagues from Europe and the United States today report the...
Jul 6, 2009 | NEWS
New risk factors for basal cell carcinoma that are independent of fair pigmentation; findings to be integrated into deCODEme™ and deCODEme Cancer™ scans Reykjavik, ICELAND, July 6, 2009 – Scientists at deCODE genetics (Nasdaq:DCGN) and academic colleagues from Europe...
Jul 1, 2009 | NEWS
Reykjavik, ICELAND, July 1, 2009 – The largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked to risk of the disease. The study, by a multinational...
Jun 29, 2009 | NEWS
Findings offer promising target for drugs to better regulate calcium metabolism, are integrated into deCODEme™ Reykjavik, ICELAND, June 29, 2009 – A discovery by scientists at deCODE genetics (Nasdaq:DCGN) and academic colleagues from Iceland, the Netherlands and...
May 20, 2009 | NEWS
Underscores quality of deCODE’s laboratory and tests, fulfilling key federal and state certification requirements and broadening marketing channels Reykjavik, ICELAND, May 20, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that its CLIA-registered DNA isolation...
